Annual CFF:
-$5.76M-$38.25M(-117.73%)Summary
- As of today, BCRX annual cash from financing is -$5.76 million, with the most recent change of -$38.25 million (-117.73%) on December 31, 2024.
- During the last 3 years, BCRX annual cash from financing has fallen by -$365.43 million (-101.60%).
- BCRX annual cash from financing is now -101.60% below its all-time high of $359.67 million, reached on December 31, 2021.
Performance
BCRX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
-$58.30M+$14.85M(+20.30%)Summary
- As of today, BCRX quarterly cash from financing is -$58.30 million, with the most recent change of +$14.85 million (+20.30%) on September 30, 2025.
- Over the past year, BCRX quarterly cash from financing has dropped by -$60.13 million (-3285.85%).
- BCRX quarterly cash from financing is now -116.78% below its all-time high of $347.42 million, reached on December 31, 2021.
Performance
BCRX Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$135.78M-$60.13M(-79.49%)Summary
- As of today, BCRX TTM cash from financing is -$135.78 million, with the most recent change of -$60.13 million (-79.49%) on September 30, 2025.
- Over the past year, BCRX TTM cash from financing has dropped by -$132.21 million (-3708.56%).
- BCRX TTM cash from financing is now -131.48% below its all-time high of $431.25 million, reached on September 30, 2022.
Performance
BCRX TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BCRX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -117.7% | -3285.8% | -3708.6% |
| 3Y3 Years | -101.6% | -176.4% | -131.5% |
| 5Y5 Years | -105.8% | -1158.1% | -174.5% |
BCRX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -101.6% | at low | -176.4% | +20.3% | -131.5% | at low |
| 5Y | 5-Year | -101.6% | at low | -116.8% | +20.3% | -131.5% | at low |
| All-Time | All-Time | -101.6% | at low | -116.8% | +20.3% | -131.5% | at low |
BCRX Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$58.30M(+20.3%) | -$135.78M(-79.5%) |
| Jun 2025 | - | -$73.15M(-7100.0%) | -$75.64M(-1764.1%) |
| Mar 2025 | - | $1.04M(+119.5%) | -$4.06M(+29.6%) |
| Dec 2024 | -$5.76M(-117.7%) | -$5.37M(-393.4%) | -$5.76M(-61.6%) |
| Sep 2024 | - | $1.83M(+217.0%) | -$3.56M(+14.5%) |
| Jun 2024 | - | -$1.56M(-137.7%) | -$4.17M(-115.6%) |
| Mar 2024 | - | -$658.00K(+79.3%) | $26.75M(-17.7%) |
| Dec 2023 | $32.48M(-63.1%) | -$3.17M(-359.0%) | $32.48M(-18.5%) |
| Sep 2023 | - | $1.23M(-95.8%) | $39.86M(-65.3%) |
| Jun 2023 | - | $29.36M(+478.2%) | $114.96M(+34.1%) |
| Mar 2023 | - | $5.08M(+20.9%) | $85.75M(-2.6%) |
| Dec 2022 | $88.03M(-75.5%) | $4.20M(-94.5%) | $88.03M(-79.6%) |
| Sep 2022 | - | $76.33M(>+9900.0%) | $431.25M(+19.9%) |
| Jun 2022 | - | $147.00K(-98.0%) | $359.70M(-1.2%) |
| Mar 2022 | - | $7.36M(-97.9%) | $364.12M(+1.2%) |
| Dec 2021 | $359.67M(+19.7%) | $347.42M(+7174.2%) | $359.67M(+70.4%) |
| Sep 2021 | - | $4.78M(+4.4%) | $211.12M(+4.7%) |
| Jun 2021 | - | $4.57M(+57.7%) | $201.71M(-33.9%) |
| Mar 2021 | - | $2.90M(-98.5%) | $305.33M(+0.9%) |
| Dec 2020 | $300.59M(+203.3%) | $198.87M(+4391.5%) | $302.70M(+66.1%) |
| Sep 2020 | - | -$4.63M(-104.3%) | $182.29M(-2.6%) |
| Jun 2020 | - | $108.20M(>+9900.0%) | $187.11M(+135.9%) |
| Mar 2020 | - | $266.00K(-99.7%) | $79.32M(-20.0%) |
| Dec 2019 | $99.10M(+58.5%) | $78.46M(>+9900.0%) | $99.10M(+351.0%) |
| Sep 2019 | - | $184.00K(-55.6%) | $21.98M(-74.4%) |
| Jun 2019 | - | $414.00K(-97.9%) | $85.71M(+2.0%) |
| Mar 2019 | - | $20.04M(+1398.9%) | $84.02M(+34.4%) |
| Dec 2018 | $62.50M(-53.9%) | $1.34M(-97.9%) | $62.50M(+1.2%) |
| Sep 2018 | - | $63.92M(+5113.2%) | $61.74M(-26.6%) |
| Jun 2018 | - | -$1.27M(+13.6%) | $84.13M(-1.6%) |
| Mar 2018 | - | -$1.48M(-357.6%) | $85.53M(-37.0%) |
| Dec 2017 | $135.70M(+482.3%) | $573.00K(-99.3%) | $135.70M(-1.3%) |
| Sep 2017 | - | $86.31M(>+9900.0%) | $137.46M(+87.1%) |
| Jun 2017 | - | $118.00K(-99.8%) | $73.48M(+2.3%) |
| Mar 2017 | - | $48.70M(+1988.3%) | $71.87M(+208.4%) |
| Dec 2016 | $23.30M(+325.3%) | $2.33M(-89.6%) | $23.30M(+11.1%) |
| Sep 2016 | - | $22.34M(+1588.0%) | $20.97M(+3029.1%) |
| Jun 2016 | - | -$1.50M(-1187.7%) | -$716.00K(-117.8%) |
| Mar 2016 | - | $138.00K(-78.7%) | $4.03M(-30.0%) |
| Dec 2015 | $5.48M(-95.1%) | - | - |
| Sep 2015 | - | $647.00K(-80.1%) | $5.75M(-32.2%) |
| Jun 2015 | - | $3.24M(+116.1%) | $8.48M(-92.4%) |
| Mar 2015 | - | $1.50M(+315.8%) | $111.01M(-0.8%) |
| Dec 2014 | $111.91M(+269.7%) | $361.00K(-89.3%) | $111.91M(-1.3%) |
| Sep 2014 | - | $3.37M(-96.8%) | $113.44M(-12.8%) |
| Jun 2014 | - | $105.77M(+4303.5%) | $130.08M(+339.0%) |
| Mar 2014 | - | $2.40M(+27.0%) | $29.63M(-2.1%) |
| Dec 2013 | $30.27M(+78.5%) | $1.89M(-90.6%) | $30.27M(+5.5%) |
| Sep 2013 | - | $20.01M(+275.8%) | $28.70M(+165.3%) |
| Jun 2013 | - | $5.33M(+75.2%) | $10.82M(+34.0%) |
| Mar 2013 | - | $3.04M(+862.0%) | $8.07M(-52.4%) |
| Dec 2012 | $16.96M(-28.6%) | $316.00K(-85.2%) | $16.96M(-2.1%) |
| Sep 2012 | - | $2.14M(-17.2%) | $17.32M(+17.5%) |
| Jun 2012 | - | $2.58M(-78.3%) | $14.75M(+29.5%) |
| Mar 2012 | - | $11.93M(+1656.3%) | $11.39M(-52.0%) |
| Dec 2011 | $23.75M(+2758.6%) | $679.00K(+254.7%) | $23.75M(+2.3%) |
| Sep 2011 | - | -$439.00K(+43.2%) | $23.22M(-2.4%) |
| Jun 2011 | - | -$773.00K(-103.2%) | $23.78M(-4.0%) |
| Mar 2011 | - | $24.29M(>+9900.0%) | $24.77M(+2882.3%) |
| Dec 2010 | $831.00K(-98.3%) | $144.60K(+19.5%) | $830.60K(-98.2%) |
| Sep 2010 | - | $121.00K(-44.2%) | $46.98M(-2.9%) |
| Jun 2010 | - | $217.00K(-37.6%) | $48.36M(+0.4%) |
| Mar 2010 | - | $348.00K(-99.2%) | $48.15M(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $47.90M(+7085.1%) | $46.29M(+2981.9%) | $47.90M(+2835.5%) |
| Sep 2009 | - | $1.50M(>+9900.0%) | $1.63M(+452.0%) |
| Jun 2009 | - | $14.00K(-84.4%) | $295.60K(+5.0%) |
| Mar 2009 | - | $90.00K(+251.6%) | $281.60K(-57.8%) |
| Dec 2008 | $666.60K(-99.0%) | $25.60K(-84.6%) | $666.60K(-1.1%) |
| Sep 2008 | - | $166.00K(>+9900.0%) | $673.90K(-99.0%) |
| Jun 2008 | - | $0.00(-100.0%) | $66.04M(-1.4%) |
| Mar 2008 | - | $475.00K(+1343.8%) | $66.95M(+0.3%) |
| Dec 2007 | $66.77M(+2154.8%) | $32.90K(-99.9%) | $66.77M(-0.1%) |
| Sep 2007 | - | $65.53M(+7109.4%) | $66.84M(+4566.9%) |
| Jun 2007 | - | $909.00K(+209.2%) | $1.43M(+41.4%) |
| Mar 2007 | - | $294.00K(+184.9%) | $1.01M(-65.8%) |
| Dec 2006 | $2.96M(-94.6%) | $103.20K(-18.1%) | $2.96M(-91.3%) |
| Sep 2006 | - | $126.00K(-74.3%) | $34.05M(-3.0%) |
| Jun 2006 | - | $490.00K(-78.1%) | $35.10M(+1.4%) |
| Mar 2006 | - | $2.24M(-92.8%) | $34.61M(-37.3%) |
| Dec 2005 | $55.18M(+156.9%) | $31.19M(+2543.1%) | $55.18M(+128.8%) |
| Sep 2005 | - | $1.18M(>+9900.0%) | $24.11M(+4.3%) |
| Jun 2005 | - | $0.00(-100.0%) | $23.13M(-3.1%) |
| Mar 2005 | - | $22.81M(>+9900.0%) | $23.86M(+11.1%) |
| Dec 2004 | $21.48M(+2287.3%) | $122.80K(-36.4%) | $21.48M(-3.3%) |
| Sep 2004 | - | $193.00K(-73.7%) | $22.22M(+0.7%) |
| Jun 2004 | - | $733.00K(-96.4%) | $22.06M(+3.4%) |
| Mar 2004 | - | $20.43M(+2272.8%) | $21.32M(+2269.3%) |
| Dec 2003 | $899.70K(+633.8%) | $861.00K(+2509.1%) | $900.00K(+2207.7%) |
| Sep 2003 | - | $33.00K(>+9900.0%) | $39.00K(+39.3%) |
| Jun 2003 | - | $0.00(-100.0%) | $28.00K(0.0%) |
| Mar 2003 | - | $6000.00(>+9900.0%) | $28.00K(-77.2%) |
| Dec 2002 | $122.60K(-34.1%) | $0.00(-100.0%) | $123.00K(-19.6%) |
| Sep 2002 | - | $22.00K(>+9900.0%) | $153.00K(-45.0%) |
| Jun 2002 | - | $0.00(-100.0%) | $278.00K(+1.5%) |
| Mar 2002 | - | $101.00K(+236.7%) | $274.00K(+47.3%) |
| Dec 2001 | $186.00K(-87.9%) | $30.00K(-79.6%) | $186.00K(-28.0%) |
| Sep 2001 | - | $147.00K(+3775.0%) | $258.40K(-17.0%) |
| Jun 2001 | - | -$4000.00(-130.8%) | $311.40K(-49.0%) |
| Mar 2001 | - | $13.00K(-87.3%) | $610.60K(-60.3%) |
| Dec 2000 | $1.54M(-96.9%) | $102.40K(-48.8%) | $1.54M(-96.8%) |
| Sep 2000 | - | $200.00K(-32.2%) | $48.39M(-3.3%) |
| Jun 2000 | - | $295.20K(-68.6%) | $50.05M(+0.6%) |
| Mar 2000 | - | $940.80K(-98.0%) | $49.76M(+1.6%) |
| Dec 1999 | $49.00M(+610.1%) | $46.95M(+2421.7%) | $48.95M(+483.7%) |
| Sep 1999 | - | $1.86M(>+9900.0%) | $8.39M(+27.1%) |
| Jun 1999 | - | $900.00(-99.3%) | $6.60M(+0.2%) |
| Mar 1999 | - | $134.10K(-97.9%) | $6.59M(-5.1%) |
| Dec 1998 | $6.90M(+3350.0%) | $6.39M(+8306.7%) | $6.95M(+1149.1%) |
| Sep 1998 | - | $76.00K(+749.6%) | $556.00K(-4.1%) |
| Jun 1998 | - | -$11.70K(-102.4%) | $580.00K(+18.0%) |
| Mar 1998 | - | $491.70K(>+9900.0%) | $491.70K(+145.8%) |
| Dec 1997 | $200.00K(-99.4%) | $0.00(-100.0%) | $200.00K(-99.1%) |
| Sep 1997 | - | $100.00K(+200.0%) | $22.60M(+2.3%) |
| Jun 1997 | - | -$100.00K(-150.0%) | $22.10M(-6.8%) |
| Mar 1997 | - | $200.00K(-99.1%) | $23.70M(-24.8%) |
| Dec 1996 | $31.50M(+275.0%) | $22.40M(+5700.0%) | $31.50M(+250.0%) |
| Sep 1996 | - | -$400.00K(-126.7%) | $9.00M(-4.3%) |
| Jun 1996 | - | $1.50M(-81.3%) | $9.40M(-43.0%) |
| Mar 1996 | - | $8.00M(+8100.0%) | $16.50M(+96.4%) |
| Dec 1995 | $8.40M(-43.6%) | -$100.00K(>-9900.0%) | $8.40M(0.0%) |
| Sep 1995 | - | $0.00(-100.0%) | $8.40M(-18.4%) |
| Jun 1995 | - | $8.60M(+8700.0%) | $10.30M(+543.8%) |
| Mar 1995 | - | -$100.00K(0.0%) | $1.60M(-89.3%) |
| Dec 1994 | $14.90M | -$100.00K(-105.3%) | $14.90M(-0.7%) |
| Sep 1994 | - | $1.90M(+2000.0%) | $15.00M(+14.5%) |
| Jun 1994 | - | -$100.00K(-100.8%) | $13.10M(-0.8%) |
| Mar 1994 | - | $13.20M | $13.20M |
FAQ
- What is BioCryst Pharmaceuticals, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. annual cash from financing year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
What is BioCryst Pharmaceuticals, Inc. annual cash from financing?
The current annual cash from financing of BCRX is -$5.76M
What is the all-time high annual cash from financing for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high annual cash from financing is $359.67M
What is BioCryst Pharmaceuticals, Inc. annual cash from financing year-on-year change?
Over the past year, BCRX annual cash from financing has changed by -$38.25M (-117.73%)
What is BioCryst Pharmaceuticals, Inc. quarterly cash from financing?
The current quarterly cash from financing of BCRX is -$58.30M
What is the all-time high quarterly cash from financing for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high quarterly cash from financing is $347.42M
What is BioCryst Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
Over the past year, BCRX quarterly cash from financing has changed by -$60.13M (-3285.85%)
What is BioCryst Pharmaceuticals, Inc. TTM cash from financing?
The current TTM cash from financing of BCRX is -$135.78M
What is the all-time high TTM cash from financing for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high TTM cash from financing is $431.25M
What is BioCryst Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
Over the past year, BCRX TTM cash from financing has changed by -$132.21M (-3708.56%)